|
Model Number VLFT10GEN |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Shock (2072); Loss of consciousness (2418); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
|
Event Date 07/08/2022 |
Event Type
Death
|
Manufacturer Narrative
|
Concomitant products: cryoflex surgical ablation probe, probe 60sf3 cryoflex 10-s 8l (serial# (b)(4)); cryoconsole, cardioblate, console r65cs1 cryoflex (serial# (b)(4)); clamp 49341 cardioblate lp ft (lot# 836c).(b)(4).Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
According to the reporter, the patient had shock.Vasopressor requirements was increased after extubation.The cardiac index was at 1.1 with worsening acidosis, acute kidney injury with elevated creatinine and uop less than 5 cc/hr, acute liver injury with elevated bilirubin, alt (alanine transaminase), ast (aspartate aminotransferase ), decreased level of consciousness and was subjected to be reintubated.Bicarb and fluids were given, tee (transesophageal echocardiogram) was unchanged from intra-op.And va ecmo (veno-arterial extracorporeal membrane oxygenation) was initiated.Following va ecmo, acidosis normalized, lactate was trending down, creatinine was trending down with increased uop, bilirubin remains elevated, alt/ast decreased, and the patient was sedated and vented.On (b)(6), uop was backed down and crrt (continuous renal replacement therapy) via ecmo circuit initiated.On (b)(6), the patient was sent to or for ecmo reconfiguration, but was unable to tolerate vv (veno-veno)and returned to va (veno-arterial).On (b)(6), the patient was sent to or for ecmo revision and converted to central ecmo.On (b)(6) 2022, ecmo was weaned off.It was reported that the patient had a blood transfusion, an extended hospitalization, and had a non-sudden cardiac death on (b)(6) 2022.
|
|
Manufacturer Narrative
|
This event has been reassessed and found not to be a reportable event.Adverse event was possibly due to procedure and not device related.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|